Neurocrine Biosciences

Create an alert
to follow the executive moves at Neurocrine Biosciences.

Neurocrine Biosciences is one of the...

• Russell 3000.

Most searched biographies at Neurocrine Biosciences

• Kevin Gorman, President, Chief Executive Officer and Director
• Leslie Norwalk, Director
• George Morrow, Director

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
PerkinElmer has announced the acquisition of Oxford Immunotec (posted on Jan 8, 2021).
Syneos Health has announced the acquisition of SynteractHCR (posted on Dec 18, 2020).

Other contacts in the Biotechnology industry

• Chandra Leo - Director at Gynesonics
• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Jean-Marc Roelandt - Chief Financial Officer at Biocartis

Learn more about the Biotechnology industry >

Latest news about Neurocrine Biosciences

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones | Neurocrine Biosciences
Neurocrine Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference | Neurocrine Biosciences
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program | Neurocrine Biosciences
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences | Neurocrine Biosciences
Neurocrine Biosciences Announces Repurchase of Convertible Notes | Neurocrine Biosciences

Neurocrine Biosciences on Wikipedia, Google News & Yahoo Finance

Neurocrine Biosciences on LinkedIn, Twitter & YouTube

Neurocrine Biosciences has 1,539 competitors including Biogen (United States (USA)), Agilyx (United States (USA)) and Eurofins (France).

Contact by email its executives including Kevin Gorman

Call Neurocrine Biosciences at +1 858....

View the org chart

Register to receive your alert

Report an error